Thursday, March 8, 2012
6:00 PM East / 5:00 PM Central /  4:00 PM Mountain / 3:00 PM Pacific


A certified one-hour live webinar for radiologists, advanced-level radiologic technologists, and other healthcare professionals who treat and manage patients with breast disease.

Click the ENROLL NOW icon to the left to register for this program

Course Overview

In February 2011, the FDA approved digital breast tomosynthesis (DBT) for use in breast imaging. The approval of DBT adds to the already wide range of breast screening and diagnostic imaging options available to physicians.

With FDA approval of DBT, the medical community is faced with evaluating DBT in terms of providing improved care for their patient population and the impact of this new technology on their medical practice. This evaluation process involves consideration of the pros and cons of the technology compared to their current practice, patient selection criteria, and operational concerns.

Faculty will present multiple pathology-proven case studies that compare views of traditional mammography to DBT. Discussion will also include strengths and weaknesses of DBT and its utility in these pathology-proven cases
 

Educational Objectives

At the conclusion of this activity, participants should be better able to:

• Explain the advantages of DBT versus traditional mammography
• Describe the technical challenges of DBT, eg, calcifications
• Discuss how DBT fits into the diagnostic and screening breast imaging paradigm

Accreditation & Credit
Credit CANNOT be granted for group viewing.  To receive credit, EACH attendee must sign in on a separate computer.

Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and the International Center for Postgraduate Medical Education (ICPME). PIM is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Postgraduate Institute for Medicine designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Radiologic Technologists
This program has been approved by American Society of Radiologic Technologists (ASRT) for 1.0 ARRT Category A+ CE credit.


How to Participate

This program is offered by ICPME through WebEx webinar service.

• Click ENROLL NOW and follow the registration instructions to register with ICPME.
• At the end of the registration process, click on ACCESS WEBINAR to complete the precourse evaluation and enroll with WebEx.
• Log-in instructions for the day of the webinar will be sent to you via e-mail upon completion of the precourse evaluation.

How to Receive Credit
There are no fees to participate in this activity. Each participant will need a computer with internet access.

• To receive credit, each participant must register, complete the precourse evaluation, attend the entire session, and complete the postcourse evaluation at the end of the session.
• Upon verification of your participation, you will receive an email with instructions to print your certificate from your online account at www.icpme.us.

Faculty Biographies

Jules H. Sumkin, DO, FACR
Dr. Sumkin is Professor of Radiology at the University of Pittsburgh School of Medicine and Chief of Radiology at the Magee-Womens Hospital of the University of Pittsburgh Medical Center.

Dr. Sumkin completed his bachelor’s degree at the University of Michigan, Ann Arbor, and medical degree in osteopathy at Ohio University, Athens. Dr. Sumkin completed a rotating internship at Doctor’s Hospital, Columbus, Ohio. He also completed a residency at Mt. Sinai Hospital, Cleveland, Ohio, and a fellowship at University of Pittsburgh Medical Center.

Dr. Sumkin’s professional memberships include the American Roentgen Ray Society, the Society of Breast Imaging, and the Radiological Society of North America. He is also an elected fellow of the American College of Radiology.

Dr. Sumkin has published over 70 articles in scientific journals, including Radiology, Medical Physics, American Journal of Roentgenology, and Journal of Surgical Oncology. He has authored a number of invited papers, proceedings, books, chapters, and has spoken widely in his areas of expertise.

Dr. Sumkin serves on the editorial board of Reports in Medical Imaging and on the international editorial board of Journal of Breast Health.


Margarita L. Zuley, MD
Dr. Zuley is an Associate Professor of Radiology at the University of Pittsburgh and the Medical Director of Breast Imaging at Magee-Womens Hospital.  She completed her residency at University of Pittsburgh Medical College and her fellowship training at Magee-Womens Hospital.

Dr. Zuley sits on several committees for the American College of Radiology, the American Board of Radiology, and the Society of Breast Imaging. She also serves as a reviewer for NIH grants and as a consultant to the FDA Radiologic Devices Panel.

Active areas of research currently include new technology evaluation, including digital breast tomosynthesis and cone beam CT. Dr. Zuley is currently the principal investigator on grants from the Susan G. Komen Foundation and from industry to investigate these new technologies. 


Conflict of Interest

The Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty below have reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
 

Jules H. Sumkin, DO, FACR has received funding for contracted research for Hologic, Inc.
Margarita L. Zuley, MD has received funding for contracted research for Hologic, Inc.

The planners and managers below reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Trace Hutchison, PharmD
Samantha Mattiucci, PharmD
Linda McLean, MS
Victoria Phoenix, BS
Lisa Schleelein, MEd
Jan Schultz, RN, MSN, CCMEP
Patricia Staples, MSN, NP-C, CCRN


Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. PIM, ICPME and Hologic do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ICPME, and Hologic. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Questions
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Phone: 607-257-5860 x10



JOINTLY SPONSORED BY

               
 


THIS ACTIVITY IS SUPPORTED BY AN EDUCATIONAL GRANT FROM

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.